[HTML][HTML] Applications of nanotechnology in drug delivery to the central nervous system

M Saeedi, M Eslamifar, K Khezri, SM Dizaj - Biomedicine & …, 2019 - Elsevier
In recent years, the researchers and drug designers have given growing attention to new
nanotechnology strategies to improve drug delivery to the central nervous system (CNS) …

Exploring the role of nanomedicines for the therapeutic approach of central nervous system dysfunction: at a glance

MM Rhaman, MR Islam, S Akash, M Mim… - Frontiers in Cell and …, 2022 - frontiersin.org
In recent decades, research scientists, molecular biologists, and pharmacologists have
placed a strong emphasis on cutting-edge nanostructured materials technologies to …

[HTML][HTML] Nanomedicine in central nervous system (CNS) disorders: a present and future prospective

S Soni, RK Ruhela, B Medhi - Advanced pharmaceutical bulletin, 2016 - ncbi.nlm.nih.gov
Purpose: For the past few decades central nervous system disorders were considered as a
major strike on human health and social system of developing countries. The natural …

Enhancement of drug permeability across blood brain barrier using nanoparticles in meningitis

KGS Nair, V Ramaiyan, SK Sukumaran - Inflammopharmacology, 2018 - Springer
The central nervous system, one of the most delicate microenvironments of the body, is
protected by the blood–brain barrier regulating its homeostasis. Blood–brain barrier is a …

Intranasal infusion of nanostructured lipid carriers (NLC) containing CNS acting drug and estimation in brain and blood

MI Alam, S Baboota, A Ahuja, M Ali, J Ali, JK Sahni - Drug delivery, 2013 - Taylor & Francis
The present study was aimed to evaluate the nanostrucured lipid carriers (NLC) containing
duloxetine (DLX-NLC) for intranasal infusion through the nasal cavity of rat. The in vivo …

Nanomedicine and Parkinson's disease: A nanoparticle medical approach

E Sobarzo-Sánchez, SM Nabavi, L Rastrelli, E Uriarte - 2018 - eprints.bmsu.ac.ir
The challenge to obtain new formulations that can give us an effective medical tool to
prepare active drugs with low bioavailability to combat Parkinson's disease, from …